SpineX reports successful first in human study results of SCONE therapy

Published On 2022-03-25 09:30 GMT   |   Update On 2022-03-25 09:30 GMT
Advertisement

SCONE, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.

SpineX, Inc., an early-stage medtech company has announced the publication of new data in the esteemed journal, BioElectric Medicine demonstrating the positive effects of SCONE therapy to treat Urge Urinary Incontinence.
To read the full story, click on the following link:
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News